Trial intelligence / Profile preview

Effects of Microplegia on Transfusion Rates After Cardiac Surgery

NCT05076604Phase 4Completed

Sponsor
Washington University School of Medicine
Start
Mar 2019
Primary completion
Jun 2023
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in aortic valve disease (AVD) and mitral valve disease, sponsored by Washington University School of Medicine. Primary endpoint: Intraoperative and Postoperative Red Blood Cell Transfusion Rates at 30 days. Started Mar 2019; status: completed.

02

Conditions

aortic valve disease (AVD)mitral valve disease

Beyond the preview

Go deeper on NCT05076604.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05076604.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call